FDA Inspection 1279827 — Groupement Interet Public Arronax
The FDA completed an inspection of Groupement Interet Public Arronax on Apr 6, 2023 in St Herblain. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 6, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- St Herblain (France)
Additional Details
Mutual Recognition Agreement (MRA)